Bilal Zulfiqar

5PUBLICATIONS
43CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsCancer cell biologyCharacterisation of biological macromoleculesBiomolecular modelling and designMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 08, 2025
Identification of potent inhibitors of Leishmania donovani and Leishmania infantum chagasi, the causative agents of Old and New World visceral leishmaniasis.

Bilal Zulfiqar, Fabio Antonio Colombo, Juliana Barbosa Nunes

|Mar 26, 2025
Connecting Bone Remodeling and Regeneration: Unraveling Hormones and Signaling Pathways.

Afshan Mehreen, Muhammad Faisal, Bilal Zulfiqar

|Feb 19, 2025
Heterocyclic core modifications in trypanosomacidal 2-[(phenylheteroaryl)ethyl]ureas.

Arthur Toynton, Lori Ferrins, Harriet L Newson

|Dec 13, 2023
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1.

Stéphanie Braillard, Martine Keenan, Karen J Breese

|Nov 24, 2021
Assay development in leishmaniasis drug discovery: a comprehensive review.

Bilal Zulfiqar, Vicky M Avery

Pageof 1

Frequent Collaborators

3 joint publications

Vicky M Avery

1 joint publications

Stéphanie Braillard

1 joint publications

Martine Keenan

1 joint publications

Karen J Breese